Home › Grants › United States › Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and...
Grant (non-repayable) Open now
- Funder
- National Institutes of Health
Funder profile and all of its programs - Amount
- Award amounts are not published in the listing; see the official page.
- Where
- United States (federal)
- Eligibility
- Open to businesses, self-employed people, nonprofits, colleges, universities, schools or research institutions and state, provincial, local or tribal governments. No cost sharing is required.
- Sectors
- Education and training, Health and life sciences, Nonprofits and charities, Research and science
- Deadline
- Closes 7 September 2028
- Source
- Grants.gov XML extract (PA-25-253)
- Last checked
- 2 November 2026
- Funder contacts
- Public organizational contacts on file Unlock full profile / Sign up
From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.
Related grant lists
Education and training Health and life sciences Nonprofits and charities Governments and public bodies Schools, colleges and research institutions Nonprofits and charities United States United States (national) Federal agency September 2028
Full eligibility results and funder contacts come with Pro and Lifetime, coming soon.
Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.